Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrence of Clostridium Difficile Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01925417
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile-associated Diarrhea

Who this might be right for
Recurrent Clostridium Difficile Infection
Rebiotix Inc. 34
Large-scale testing (Phase 3)UnknownNCT06107569
What this trial is testing

Treatment of CDI and Recurrence With Fecal Microbiota Transplant Using Promicrobioma

Who this might be right for
Clostridium Difficile Infections
Hospital Universitario Evangelico de Curitiba 24
Large-scale testing (Phase 3)UnknownNCT02774382
What this trial is testing

Rectal Bacteriotherapy, Fecal Microbiota Transplantation or Oral Vancomycin Treatment of Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile
Hvidovre University Hospital 450
Testing effectiveness (Phase 2)Looking for participantsNCT07285213
What this trial is testing

Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal Antibody

Who this might be right for
Clostridioides Difficile Infection
AstraZeneca 230
Early research (Phase 1)Study completedNCT02830542
What this trial is testing

SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence

Who this might be right for
Clostridium Difficile Infection
Seres Therapeutics, Inc. 96
Large-scale testing (Phase 3)UnknownNCT04960306
What this trial is testing

Fecal Filtrate as a Treatment Option of Multiple Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile Infection
University of Pecs 238
Testing effectiveness (Phase 2)Study completedNCT01398969
What this trial is testing

Multi-Centre Trial of Fresh vs. Frozen-and-Thawed FMT for Recurrent CDI

Who this might be right for
Clostridium Difficile Infection
McMaster University 232
Testing effectiveness (Phase 2)Ended earlyNCT03617172
What this trial is testing

PROCLAIM -- Misoprostol in the Prevention of Recurrent CDI Prevent Recurrence of Clostridium Difficile Infection With Misoprostol

Who this might be right for
Clostridium Difficile
Vanderbilt University Medical Center 6
Testing effectiveness (Phase 2)WithdrawnNCT01077245
What this trial is testing

Safety and Clinical Effectiveness of Oral Probiotic MIYA-BM to Prevent Recurrent Clostridium Difficile Infections

Who this might be right for
Clostridium Difficile Infection
Osel, Inc.
Not applicableLooking for participantsNCT07250724
What this trial is testing

C. Difficile Toxin Levels in Stool From Healthy Individuals Following Standard of Care Antibiotic Treatment for CDI.

Who this might be right for
Clostridioides Difficile Infection Recurrence
Bactolife A/S 60
Not applicableStudy completedNCT02214771
What this trial is testing

Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

Who this might be right for
Clostridium Difficile Infection
Astellas Pharma S.A.S. 296
Not applicableLooking for participantsNCT07374094
What this trial is testing

Clostridioides Difficile: Understanding Responses and Treatment Effects

Who this might be right for
Clostridioides Difficile Infection
Umeå University 200
Large-scale testing (Phase 3)Active Not RecruitingNCT05330182
What this trial is testing

LMN-201 for Prevention of C. Difficile Infection Recurrence

Who this might be right for
Clostridioides Difficile Infection
Lumen Bioscience, Inc. 375
Large-scale testing (Phase 3)Ended earlyNCT01226992
What this trial is testing

Oral Vancomycin Followed by Fecal Transplant Versus Tapering Oral Vancomycin

Who this might be right for
Recurrent Clostridium Difficile InfectionLaboratory Confirmed Clostridium Difficile Infection
University Health Network, Toronto 81
Testing effectiveness (Phase 2)WithdrawnNCT04729790
What this trial is testing

Randomized Clinical Trial of Standard FMT Treatments

Who this might be right for
Clostridium Difficile
The University of Texas Health Science Center, Houston
Testing effectiveness (Phase 2)Study completedNCT02589847
What this trial is testing

Microbiota Restoration Therapy for Recurrent Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile Infection
Rebiotix Inc. 272
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Early research (Phase 1)Study completedNCT04891965
What this trial is testing

ART24 in Subjects Recently Cured of a Clostridioides Difficile Infection (CDI)

Who this might be right for
Clostridium Difficile Infection Recurrence
Adiso Therapeutics 36
Testing effectiveness (Phase 2)Study completedNCT02437487
What this trial is testing

SER-109 Versus Placebo to Prevent Recurrent Clostridium Difficile Infection (RCDI)

Who this might be right for
Clostridium Difficile
Seres Therapeutics, Inc. 89
Testing effectiveness (Phase 2)Looking for participantsNCT07513285
What this trial is testing

ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection

Who this might be right for
Clostridium Difficile Infection Recurrence
Acurx Pharmaceuticals Inc. 20
Next Page